111.1 Sequential genome editing enhances triple-knockout efficiency and human transgene expression in porcine fibroblasts for xenotransplantation
Prof. Adrian Mutto, Argentina
111.2 Biocompatibility of genetically-engineered pig cornea in corneal xenotransplantation for the use of human clinical trials
Prof. Chung Young Kim, Korea
111.3 Genome-engineered porcine expanded potential stem cells as a novel cellular source for xenotransplantation
Dr. Yiyi Xuan, Hong Kong
111.4 Identification of the potential role of swine leukocyte antigen in xenotransplantation
Ms. nayoung Ko, Korea
111.5 Human thrombomodulin-expressing Transgenic pigs for islet xenotransplantation: Potential Implication for pancreatic function and disease
Mr. Kyungmin Kwak, Korea
111.6 Overexpression of human CD55 in tripple knocout (TKO) porcine red blood cells (pRBC) can further reduce human antibody-induced hemolytic reactions
Miss Yong Wang, People's Republic of China
111.7 A novel transgene to regulate oxidative stress and mitochondrial damage